心脏术后多器官衰竭患者中的急性肠系膜缺血
该回顾性观察研究纳入2007至2013年某大学医院两个ICU收治的4948例心脏术后患者,其中320例(6%)因多器官衰竭入ICU,33例(10%)经腹部CT、消化内镜、剖腹术或尸检确认急性肠系膜缺血(AMI)。AMI患者28天死亡率64%、90天死亡率83%,83%为非闭塞性肠系膜缺血(NOMI)。冠状动脉旁路移植术、体外循环期间需输血、天冬氨酸氨基转移酶至少100 UI/L、入ICU时简化急性生理评分II至少50分与AMI独立相关,基于这四项的风险评分可区分低危(<1%)、中危(9%)、高危(29%)三类风险。作者认为应进一步推进预防和早期诊断。
要点
- 心脏术后因多器官衰竭入ICU的患者中AMI发生率为10%(33/320),预后极差,28天死亡率64%、90天死亡率83%。
- AMI主要机制为NOMI,占83%。
- 独立相关因素包括冠状动脉旁路移植术、体外循环期间需输血、天冬氨酸氨基转移酶至少100 UI/L、入ICU时简化急性生理评分II至少50分。
- 基于上述四项的风险评分可识别低危(<1%)、中危(9%)、高危(29%)三类风险。
- 作者认为应进一步推进预防和早期诊断。
适用人群与场景
- 心脏手术后需入住ICU的多器官衰竭患者;研究纳入某大学医院两个ICU于2007至2013年收治的心脏术后患者。
诊断标准与关键阈值
- AMI确认基于腹部计算机断层扫描、消化内镜、剖腹术或尸检。
- 入ICU时简化急性生理评分II至少50分与AMI独立相关。
- 天冬氨酸氨基转移酶至少100 UI/L与AMI独立相关。
研究设计与关键结果
- 回顾性观察研究:2007至2013年4948例心脏手术患者中320例(6%)因多器官衰竭入ICU,其中33例(10%)确认AMI。
- AMI患者28天死亡率64%、90天死亡率83%。
- NOMI占AMI患者的83%。
- 冠状动脉旁路移植术、体外循环期间需输血、天冬氨酸氨基转移酶至少100 UI/L、入ICU时简化急性生理评分II至少50分与AMI独立相关。
- 基于四项风险因素的风险评分识别低危(<1%)、中危(9%)、高危(29%)三类。
证据类型、等级与局限
- 证据类型:回顾性观察研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对心脏术后因多器官衰竭入ICU的患者,应认识到AMI发生率为10%、NOMI占83%,28天死亡率64%、90天死亡率83%。
- 可依据冠状动脉旁路移植术、体外循环期间需输血、天冬氨酸氨基转移酶至少100 UI/L、入ICU时简化急性生理评分II至少50分四项因素评估AMI风险,风险评分可区分低危(<1%)、中危(9%)、高危(29%)。
- 作者认为应进一步推进预防和早期诊断。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Acute mesenteric ischemia (AMI) is a rare but severe complication after cardiac surgery. However, AMI is likely to be more frequent in the subgroup of patients presenting with multiple organ failure after a cardiac surgery. The primary objective of this study was to identify AMI risk factors among patients requiring intensive care unit (ICU) admission after cardiac surgery.
METHODS: Retrospective observational study of all the patients requiring admission to two ICUs in a large university hospital after a cardiac surgery procedure. AMI confirmation was based on abdominal computed tomography scan, digestive endoscopy, laparotomy, or postmortem examination. Univariate and multivariate analyses were done to compare pre- and in-ICU characteristics between patients with or without AMI.
RESULTS: Between 2007 and 2013, a cardiac surgery was performed in 4,948 patients, of whom 320 patients (6%) required ICU admission for multiple organ failure. AMI was confirmed in 10% of the patients admitted to the ICU for multiple organ failure (33/320). The prognosis of these patients was extremely poor with 28- and 90-day mortality rates of 64% and 83%, respectively. Nonocclusive mesenteric ischemia (NOMI) was the main mechanism involved in 83% of the patients. Coronary artery bypass graft, need for blood transfusion during cardiopulmonary bypass, aspartate aminotransferase at least 100 UI/L, and Simplified Acute Physiology Score II at least 50 at ICU admission were independently associated with AMI. An AMI risk score based upon these four risk factors was able to identify three classes of risk: low risk (<1%), intermediate risk (9%), and high risk (29%).
CONCLUSION: AMI is a frequent condition among patients presenting with multiple organ failure after cardiac surgery, occurring in 10% of them. The prognosis of AMI is extremely poor. The main mechanism of AMI is NOMI, occurring in approximately 80% of patients. Further progress should be performed on prevention and earlier diagnosis.
参考来源
- Guillaume A, Pili-Floury S, Chocron S, et al. Acute Mesenteric Ischemia Among Postcardiac Surgery Patients Presenting with Multiple Organ Failure. Shock. 2017. PMID: 28195969. doi:10.1097/SHK.0000000000000720
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。